David Bryant

Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom

Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship.

Part of Triley Bidco Ltd., Clinigen Healthcare Ltd. is a British company founded in 2007 that has more than 30 years of experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company is based in Burton-on-Trent, UK. The company's investigator-initiated studies services provide smart solutions to investigators, with managed regulatory pathways required for support of IIS & EAP programs. Through the Clinigen Management Access, patient and healthcare professionals are granted access to the medicines they need.

Keats Healthcare Ltd. engages in manufacturing and processing of drugs in pharmaceutical preparations for human or veterinary use. The company was founded on May 15, 2008 and is headquartered in Burton-On-Trent, the United Kingdom.

Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million.

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Bionical Ltd. supplies and manages medicines to the clinical trial, bio-similar and bio-analytical sectors. It provides global clinical trial, sourcing and supply solution. The firm also provides product acquisition services, which include distribution, marketing and management of products. The company was founded by Andrew Derrick Leaver in 2009 and is headquartered in Willington, the United Kingdom.

Clarity Pharma Ltd. provides pharmaceutical licensing and marketing services. The private company is based in Stansted, UK. and has subsidiaries in United Kingdom. The British company was founded by Andrew Derrick Leaver. The CEO is Tanya Monteith.

Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK.

Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company.

Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017.

Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company.

Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans.

Part of Triley Bidco Ltd., Idis Group Ltd. functions as an investment holding British company. The company is based in Burton-On-Trent, UK.

Penn Pharmaceutical Services Ltd. provides drug development, clinical trial supply and pharmaceutical manufacturing services. Its services include solid oral and topical products formulation, pilot batches scale up and testing, clinical trials supplies manufacturing, process validation and technology transfer, formulation and analytical development, clinical trial packing and labeling, and storage and distribution. The company was founded in 1977 and is headquartered in Tredegar, the United Kingdom.

Mitre Group Ltd. provides sports and stadia training services. The firm consults on providing apprenticeships, staff development courses and pre-employment programmes. It offers coach education, sports development, youth work, stadia safety, management and leadership, customer service, employability skills, health and safety and first aid. The company is headquartered in Derby, the United Kingdom.

Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom.

Zeneca Pharmaceuticals manufactures medicines.

Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland.

Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom.

AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.

Great Point Partners Private Equity (Great Point Partners) is a private equity subsidiary of Great Point Partners LLC founded in 2003 by Jeffrey Robert Jay and David Eric Kroin. The firm is headquartered in Greenwich, Connecticut.

Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy.

Part of Abbott Laboratories, Abbott Ireland Ltd. is an Irish company that helps people live healthier lives through their life-changing technology. The company is based in Dublin, Ireland. The company's technology focuses on keeping the heart healthy, nourishing the body at every stage of life, improving movement, and providing information, medicines, and breakthroughs to manage health.

DCTLawrence, Inc. provides home health care services. The company is based in Liberty Lake, WA and has subsidiaries in United Kingdom and United States. The company was founded in 1996 by Jeffrey Wiberg and David Lawrence, with Jeffrey Wiberg serving as CEO since then.

Tergus Pharma LLC operates as a pharmaceutical research, development, testing, analysis, and manufacturing firm. It offers formulation development, analytical research and development, regulatory support, skin permeation studies, franz diffusion, and consulting. The company was founded by Vijendra Nalamothu and Kailas Thakker and is headquartered in Durham, NC.